CAS 1096708-71-2

4-Pyrimidinecarboxamide, 6-amino-5-chloro-n-[(1r)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-

CAS: 1096708-71-2

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Purity: 99%

Color and Shape: Solid

Molecular weight: 506.2891

Ref: IN-DA008TIA

TAK-580

CAS: 1096708-71-2

TAK-580

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Purity: ≥98%

Molecular weight: 506.29

Ref: 54-BUP03222

Tovorafenib

CAS: 1096708-71-2

(R)-2-(1-(6-Amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Purity: 99%

Molecular weight: 506.29

Ref: IN-DG287791

Tovorafenib

CAS: 1096708-71-2

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Molecular weight: 506.29

Ref: 4Z-T-469001

TAK-580

CAS: 1096708-71-2

TAK-580 (MLN2480) is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Purity: 99.60% - 99.77%

Color and Shape: White Solid

Molecular weight: 506.29

Ref: TM-T6895

MLN2480

Controlled Product

CAS: 1096708-71-2

Applications MLN2480 is a RAF inhibitor that is used for the treatment of melanoma.

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Color and Shape: Neat

Molecular weight: 506.29

Ref: TR-M425140

BIIB-024

CAS: 1096708-71-2

BIIB-024 is a monoclonal antibody that targets mutant melanoma cells. It binds to the tumor and prevents it from growing, as well as preventing the cancer cells from spreading. BIIB-024 has shown effectiveness in clinical studies by reducing tumor size and skin reactions in patients with melanoma. The effective dose of BIIB-024 is 10 milligrams per kilogram of body weight. BIIB-024 also inhibits protein synthesis in tumor cells, which may be due to its ability to bind to cytosolic proteins.

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Purity: Min. 95%

Molecular weight: 506.29 g/mol

Ref: 3D-FB103923

Tovorafenib

CAS: 1096708-71-2

Formula: C₁₇H₁₂Cl₂F₃N₇O₂S

Molecular weight: 506.3

Ref: ST-EA-CP-T220000